WuXi XDC makes an ADC linker deal with Earendil for up to $885Mnews2026-02-27T16:13:26+00:00February 27th, 2026|Endpoints News|
Chinese Academy of Sciences proposes capping pay-to-publish fees for high-profile journalsnews2026-02-27T15:25:00+00:00February 27th, 2026|Chemistry World|
Ginkgo divests biosecurity arm; J&J’s early prostate cancer datanews2026-02-27T15:14:31+00:00February 27th, 2026|Endpoints News|
Vatech Reports Industry-Leading 20-Year Patent Portfolio in Dental Diagnostic Imagingnews2026-02-27T15:03:34+00:00February 27th, 2026|Medical Device News Magazine|
Padcev-Keytruda combo delivers more positive data in bladder cancernews2026-02-27T15:00:05+00:00February 27th, 2026|Endpoints News|
Novartis closes Avidity deal as rare heart disease spinout launchesnews2026-02-27T14:51:42+00:00February 27th, 2026|Endpoints News|
Blue Earth Diagnostics Reports Favorable Head‑to‑Head Study Results Comparing POSLUMA® (Flotufolastat F 18) and Piflufolastat F 18 for Assessing Urinary Bladder Radioactivity in Men with Biochemical Recurrent Prostate Cancernews2026-02-27T14:49:26+00:00February 27th, 2026|Medical Device News Magazine|
Synergy Spine Solutions Earns FDA Approval for the Synergy Disc, Advancing Cervical Disc Replacement in the U.S.news2026-02-27T14:36:07+00:00February 27th, 2026|Medical Device News Magazine|
